Drug development
Drug Development
Drug development (pronunciation: /drʌg dɪˈvɛləpmənt/) is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.
Etymology
The term "drug development" is derived from the English words "drug", which is from the Old French "drogue" (meaning 'a pharmaceutical substance'), and "development", which comes from the Old French "desveloper" (meaning 'to unwrap, unfurl').
Process
The drug development process includes several stages such as preclinical research, both microdosing studies and in vitro and in vivo testing, clinical trials (Phase I, II, III and sometimes IV), and finally, regulatory approval by agencies such as the Food and Drug Administration (FDA) or the European Medicines Agency (EMA).
Related Terms
- Drug Discovery: The process by which new candidate medications are discovered.
- Clinical Trials: Experiments or observations done in clinical research.
- Pharmacokinetics: The study of how an organism affects a drug.
- Pharmacodynamics: The study of the biochemical and physiological effects of drugs on the body.
- Toxicology: The study of the adverse effects of chemical substances on living organisms.
See Also
External links
- Medical encyclopedia article on Drug development
- Wikipedia's article - Drug development
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski